Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Richmond
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Richmond, VA

Studies commonly pay $75 to $4,500 per completed study

608 clinical trials are currently recruiting participants within 30 miles of Richmond. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

608studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Richmond right now

Top 25 of 608 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Bon Secours Richmond Community Hospital — Richmond, Virginia (1.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
VCU — Richmond, Virginia (1.9 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
VCU Massey Comprehensive Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Any Solid Oral Medication N/A Interventional 200 participants sought
Virginia Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: Dosentrx Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06344416)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
VCU Health Adult Outpatient Pavillion ( Site 0138) — Richmond, Virginia (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Richmond, Virginia (1.9 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

Heart Failure, Congestive, Death, Sudden, Cardiac N/A Observational 1,500 participants sought
Virginia Commonwealth University School of Medicine — Richmond, Virginia (1.9 mi) · Sponsor: Johns Hopkins University
See eligibility & contact on ClinicalTrials.gov (NCT00733590)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retina Institute of Virginia — Richmond, Virginia (1.9 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

Motor Adaptation and Generalization, Posterior Parietal Cortex N/A Interventional 60 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi) · Sponsor: Virginia Commonwealth University
See eligibility & contact on ClinicalTrials.gov (NCT05947279)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Richmond, Virginia (1.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Richmond, Virginia (1.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Colo-rectal Cancer Phase 2 Interventional 79 participants sought
Virginia Commonwealth University - Massey — Richmond, Virginia (1.9 mi) · Sponsor: NSABP Foundation Inc
See eligibility & contact on ClinicalTrials.gov (NCT07058012)

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Prediabetic State, Atherosclerosis Phase 4 Interventional 7,410 participants sought
Hunter Holmes McGuire VA Medical Center, Richmond, VA — Richmond, Virginia (1.9 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT02915198)

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Multiple conditions Phase 1 Interventional 46 participants sought
VCU Massey Comprehensive Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05172245)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Chippenham Hospital — Richmond, Virginia (1.9 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis Phase 2 Interventional 180 participants sought
Virginia Commonwealth University (a public institution of higher education) — Richmond, Virginia (1.9 mi) · Sponsor: ACADIA Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07029581)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
VCU Health Adult Outpatient Pavillion ( Site 0080) — Richmond, Virginia (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT03486873)

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Multiple Myeloma Phase 2 Interventional 210 participants sought
Virginia Commonwealth University - Massey Cancer Center — Richmond, Virginia (1.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06500884)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Bon Secours Saint Mary's Hospital — Richmond, Virginia (1.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)
Actively enrolling

Studies you may be able to join near Richmond

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Richmond

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Trials of Virginia

6767 Forest Hill Ave #305, Richmond, VA 23225
(804) 330-9410

Wright Center for Clinical and Translational Research

1200 E Clay St, Richmond, VA 23298
(804) 827-1531

Clinical Research Partners

★ 4.9 (66 reviews)
7110 Forest Ave, Richmond, VA 23226
(804) 477-3045
"This was a really friendly environment. Piyali made the process very smooth and was so kind and friendly. Any worries I had she addressed and made me…"
— YoshiRocker 7, 5★

National Clinical Research

★ 5.0
2809 Emerywood Pkwy #140, Richmond, VA 23294
(804) 672-2995

VCU Medical Center - Laboratory

★ 2.0
401 N 13th St, Richmond, VA 23298
(804) 828-7284
"Called this number because it was listed publicly on Google and due to my lab results not being available 72 hours after the draw.. Person who answer…"
— Penny, 1★

CARI Center

203 E Cary St, Richmond, VA 23219
(804) 639-9267

Richmond City Health District

★ 3.4
400 E Cary St, Richmond, VA 23219
(804) 482-5500
"Everyone in the process was kind, professional, and very efficient. I was surprised to see how fast everything was to get tested. A huge resource for…"
— Isaiah Cabino, 5★

VCU Medical Center North Hospital

★ 3.3
1300 E Marshall St, Richmond, VA 23219
(804) 828-9000
"My wife gave birth at this hospital, and unfortunately, our experience was extremely traumatic due to what we believe was negligence by Dr. Amanda Ri…"
— Patrick Powell, 1★

Retreat Doctors' Hospital

★ 4.6
2621 Grove Ave, Richmond, VA 23220
(804) 254-5100
"The best hospital in Richmond..the staff treats you like family...the 5th floor is the greatest and these people care for you like you're their own: …"
— Sasha Foster, 5★

Clinical trials in Richmond: what's recruiting

The Richmond area currently has 608 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Richmond, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular3 studies
  • Immune & Skin1 studies
  • Brain & Mental Health1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Richmond, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Richmond

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Richmond participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Richmond?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Richmond safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Richmond?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Richmond.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Richmond typically complete one or two studies per year.

Paid clinical trials near Richmond

Other metros within reach

Fredericksburg, VA33 Newport News, VA381 Alexandria, VA2,289 Norfolk, VA400 Arlington, VA2,331 Chesapeake, VA401 Washington, DC2,362 Virginia Beach, VA400

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Richmond Chronic Kidney Disease (HealthMatch) in Richmond Bladder Issues Due To Spinal Cord Injury in Richmond All conditions

More of VA

Arlington2,331 Alexandria2,289 Chesapeake401 Virginia Beach400 Norfolk400 Newport News381 Roanoke194 Fredericksburg33

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts